Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 2/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 8/20 | 0.38 |
| ▸ | BTK | Q06187 | 2/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CD38 | P28907 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19004853 | 0.83 | IRAK4 (0.43) | HPGDSIRAK4EGFRLMNAPKM | |
| SCHEMBL19004849 | 0.78 | HPGDS (0.44) | HPGDSIRAK4MAP4K4EGFRLMNA | |
| SCHEMBL28890932 | 0.77 | HPGDS (0.42) | HPGDSIRAK4BTKMAP4K4EGFR | |
| SCHEMBL23555498 | 0.74 | IRAK4 (0.44) | HPGDSIRAK4BTKMAP4K4EGFR | |
| SCHEMBL767164 | 0.70 | HPGDS (0.42) | HPGDSIRAK4MAP4K4EGFRLMNA | |
| SCHEMBL21159561 | 0.69 | HPGDS (0.53) | HPGDSMAP4K4EGFRLMNAHTT | |
| SCHEMBL15221628 | 0.65 | LRRK2 (0.40) | HPGDSIRAK4HSD17B10 | |
| SCHEMBL21138485 | 0.65 | CD38 (0.40) | HPGDSIRAK4BTKMAP4K4EGFR | |
| SCHEMBL21138338 | 0.64 | HPGDS (0.47) | HPGDSMAP4K4EGFRLMNAHTT | |
| SCHEMBL30808262 | 0.64 | HPGDS (0.47) | HPGDSMAP4K4EGFRLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017102091-A1 | HETEROARYLBENZIMIDAZOLE COMPOUNDS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-06-22 | — | — | WO | disclosed |